No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
55% Of This GoodRx Holdings Insider's Holdings Were Sold
Raymond James Adds UnitedHealth, Drops GoodRx From Favorites List
TD Cowen Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $10
Mizuho Securities Maintains GoodRx(GDRX.US) With Hold Rating
Truist Financial Maintains GoodRx(GDRX.US) With Hold Rating
GoodRx Holdings: Navigating Leadership Transition and Legislative Uncertainty